Providence Capital Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.95M Buy
15,079
+141
+0.9% +$50.6K 0.81% 54
2025
Q4
$5.25M Buy
14,938
+96
+0.6% +$35K 0.88% 48
2025
Q3
$5.49M Buy
14,842
+409
+3% +$158K 0.95% 44
2025
Q2
$5.71M Buy
14,433
+472
+3% +$177K 1.05% 45
2025
Q1
$5.2M Buy
13,961
+346
+3% +$132K 1.08% 38
2024
Q4
$4.9M Buy
+13,615
New +$5.05M 0.99% 48
2023
Q4
Sell
-11
Closed -$3.01K 371
2023
Q3
$3.01K Buy
+11
New +$3.15K ﹤0.01% 281

Other funds holding SYK

Providence Capital Advisors's SYK Position: Q1 2026 in Review

Providence Capital Advisors increased its Stryker (SYK) stake by 0.94% in Q1 2026, buying an estimated $50.6K and bringing the position to 15,079 shares worth $4.95M. The position accounts for 0.81% of the portfolio, ranked #54.

Providence Capital Advisors first reported a position in SYK in Q3 2023 and has held it in 7 quarters since. The position peaked at $5.71M in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Providence Capital Advisors held 15,079 shares of Stryker worth $4.95M as of Q1 2026.
  • Providence Capital Advisors bought 141 Stryker shares in Q1 2026, an estimated $50.6K.
  • Stryker made up 0.81% of Providence Capital Advisors's portfolio in Q1 2026, its #54 holding.
  • Providence Capital Advisors first reported a position in Stryker in Q3 2023 and has held it in 7 quarters since.
  • Providence Capital Advisors's Stryker position peaked at $5.71M in Q2 2025.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Providence Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.